ID
43669
Description
Study ID: 100551 (EXT Y11) Clinical Study ID: 100551 Study Title: A double blind randomised, comparative study of the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals’ combined hepatitis A - hepatitis B vaccine when administered in healthy adults Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00289770 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: Hepatitis A (Inactivated), Hepatitis B (Recombinant) Vaccine Trade Name: Twinrix Study Indication: Hepatitis A; Hepatitis B
Mots-clés
Versions (3)
- 26/06/2017 26/06/2017 -
- 26/09/2017 26/09/2017 -
- 20/09/2021 20/09/2021 -
Téléchargé le
20 septembre 2021
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Comparative study of the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals’ combined hepatitis A - hepatitis B (Visit 21 Year 14)
Comparative study of the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals’ combined hepatitis A - hepatitis B (Visit 21 Year 14)
Description
General Information
Alias
- UMLS CUI-1
- C1508263
Description
Date of visit
Type de données
date
Alias
- UMLS CUI [1]
- C1320303
Description
Subject Number
Type de données
integer
Alias
- UMLS CUI [1]
- C2348585
Description
I certify that Informed Consent has been obtained prior to any study procedure.
Type de données
date
Alias
- UMLS CUI [1]
- C0021430
Description
Demographics
Alias
- UMLS CUI-1
- C1704791
Description
Center number
Type de données
integer
Alias
- UMLS CUI [1,1]
- C1301943
- UMLS CUI [1,2]
- C0600091
Description
Date of birth
Type de données
date
Alias
- UMLS CUI [1]
- C0421451
Description
Gender
Type de données
text
Alias
- UMLS CUI [1]
- C0079399
Description
Race
Type de données
text
Alias
- UMLS CUI [1]
- C0034510
Description
Race: Specification
Type de données
text
Alias
- UMLS CUI [1,1]
- C0034510
- UMLS CUI [1,2]
- C2348235
Description
Laboratory tests
Alias
- UMLS CUI-1
- C0022885
Description
Anti-HAV and anti-HBs antibodies
Type de données
text
Alias
- UMLS CUI [1]
- C0201473
- UMLS CUI [2]
- C0201478
Description
Collection Date
Type de données
date
Alias
- UMLS CUI [1]
- C1317250
Description
Hepatitis A or Hepatitis B vaccine
Type de données
text
Alias
- UMLS CUI [1,1]
- C0170300
- UMLS CUI [1,2]
- C2240392
Description
Hepatitis A or Hepatitis B vaccine: Specification
Type de données
text
Alias
- UMLS CUI [1,1]
- C0170300
- UMLS CUI [1,2]
- C2348235
- UMLS CUI [2,1]
- C2240392
- UMLS CUI [2,2]
- C2348235
Description
Hepatitis A or Hepatitis B immunoglobulins
Type de données
text
Alias
- UMLS CUI [1]
- C3652495
- UMLS CUI [2]
- C0062525
Description
Specification of Hepatitis A or Hepatitis B immunoglobulins
Type de données
text
Alias
- UMLS CUI [1,1]
- C3652495
- UMLS CUI [1,2]
- C2348235
- UMLS CUI [2,1]
- C0062525
- UMLS CUI [2,2]
- C2348235
Description
Hepatitis A or B infection
Type de données
boolean
Alias
- UMLS CUI [1]
- C0019159
- UMLS CUI [2]
- C0019163
Description
Serology conclusion before booster
Alias
- UMLS CUI-1
- C0036743
Description
Please complete this section only after receipt of the serology results related to the assessment done at visit 21.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0201478
Description
If YES to any of above, subject will receive either ENGERIX™, HAVRIX™ or TWINRIX™ ADULT as appropriate. Please complete the entire Case Report Form. If NO to both questions, please complete the study conclusion section only.
Type de données
boolean
Alias
- UMLS CUI [1]
- C0062524
Similar models
Comparative study of the immunogenicity and reactogenicity of three different lots of GlaxoSmithKline Biologicals’ combined hepatitis A - hepatitis B (Visit 21 Year 14)
C0579004 (UMLS CUI-2)
C0600091 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])
C0201478 (UMLS CUI [2])
C2240392 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])
C2240392 (UMLS CUI [2,1])
C2348235 (UMLS CUI [2,2])
C0062525 (UMLS CUI [2])
C2348235 (UMLS CUI [1,2])
C0062525 (UMLS CUI [2,1])
C2348235 (UMLS CUI [2,2])
C0019163 (UMLS CUI [2])